1. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016:64;1388-42.
2. Basu R, Noureddin M, Clark JM. Nonalcoholic fatty liver disease: review of management for primary care providers. Mayo Clin Proc 2022; 97:1700-16. https://doi.org/10.1016/j.mayocp.2022.04.005.
3. Eslam M, Sarin SK, Wong VWS, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020; 14:889-919. https://doi.org/10.1007/s12072-020-10094-2.
4. Ando Y, Jou JH. Non-alcoholic fatty liver disease and recent guideline updates. Clinical Liver Disease. 2021;17(1):23-8.
11. Rinella ME, Neuschwander-Tetri BA, Siddiqul MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guideline on the clinical assessment and management of non-alcoholic fatty liver disease. Hepatology. 2023; 77:1797-1835.
12. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. 2017. https://doi.org/10.1002/hep.29367/ suppinfo.